Protara Therapeutics Management
Management criteria checks 3/4
Protara Therapeutics' CEO is Jesse Shefferman, appointed in Nov 2017, has a tenure of 6.42 years. total yearly compensation is $2.78M, comprised of 21.1% salary and 78.9% bonuses, including company stock and options. directly owns 7.32% of the company’s shares, worth $2.51M. The average tenure of the management team and the board of directors is 2.3 years and 4.3 years respectively.
Key information
Jesse Shefferman
Chief executive officer
US$2.8m
Total compensation
CEO salary percentage | 21.1% |
CEO tenure | 6.4yrs |
CEO ownership | 7.3% |
Management average tenure | 2.3yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Protara: A Bombed Out Biotech With A Very Positive Skew
Feb 22Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation
Dec 16We Think Protara Therapeutics (NASDAQ:TARA) Can Afford To Drive Business Growth
Apr 22The Prognosis For Protara Therapeutics
Oct 13Here's Why We're Not Too Worried About Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation
Sep 12Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?
Mar 21Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Deliver On Growth Plans?
Dec 06Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?
Aug 17CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$40m |
Sep 30 2023 | n/a | n/a | -US$69m |
Jun 30 2023 | n/a | n/a | -US$67m |
Mar 31 2023 | n/a | n/a | -US$64m |
Dec 31 2022 | US$3m | US$588k | -US$66m |
Sep 30 2022 | n/a | n/a | -US$37m |
Jun 30 2022 | n/a | n/a | -US$40m |
Mar 31 2022 | n/a | n/a | -US$45m |
Dec 31 2021 | US$4m | US$570k | -US$47m |
Sep 30 2021 | n/a | n/a | -US$46m |
Jun 30 2021 | n/a | n/a | -US$43m |
Mar 31 2021 | n/a | n/a | -US$37m |
Dec 31 2020 | US$8m | US$507k | -US$34m |
Sep 30 2020 | n/a | n/a | -US$28m |
Jun 30 2020 | n/a | n/a | -US$22m |
Mar 31 2020 | n/a | n/a | -US$16m |
Dec 31 2019 | US$379k | US$344k | -US$8m |
Sep 30 2019 | n/a | n/a | -US$7m |
Dec 31 2018 | US$301k | US$268k | -US$4m |
Compensation vs Market: Jesse's total compensation ($USD2.78M) is above average for companies of similar size in the US market ($USD667.11K).
Compensation vs Earnings: Jesse's compensation has been consistent with company performance over the past year.
CEO
Jesse Shefferman (51 yo)
6.4yrs
Tenure
US$2,780,896
Compensation
Mr. Jesse Shefferman is the Co-Founder of Proteon Therapeutics Inc. (Formerly known as Protara Therapeutics, Inc. (formerly known as ArTara Therapeutics, Inc.).) and served as its Principal Financial Offic...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 6.4yrs | US$2.78m | 7.32% $ 2.5m | |
Co-Founder | 3.3yrs | US$1.30m | 0.55% $ 190.0k | |
Executive Officer | 2.5yrs | US$1.17m | 0.12% $ 40.6k | |
Chief Financial Officer | 1.3yrs | no data | no data | |
VP, Principal Accounting Officer & Controller | 1.8yrs | no data | 0.15% $ 51.1k | |
Senior Vice President of Investor Relations & Corporate Affairs | 2.3yrs | no data | no data | |
General Counsel & Corporate Secretary | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
42yo
Average Age
Experienced Management: TARA's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | no data | US$2.78m | 7.32% $ 2.5m | |
Independent Chairman of the Board | 5.5yrs | US$197.11k | 0.26% $ 90.0k | |
Independent Director | 4.3yrs | US$123.11k | 0.27% $ 93.0k | |
Independent Director | 4.4yrs | US$80.61k | 0.27% $ 93.0k | |
Independent Director | 4.3yrs | US$77.02k | 0.23% $ 79.5k | |
Independent Director | 5.3yrs | US$96.61k | 0% $ 0 | |
Independent Director | 3.3yrs | US$77.19k | 0% $ 0 | |
Independent Director | 3.8yrs | US$71.61k | 0% $ 0 | |
Independent Director | 2.8yrs | US$90.61k | 0% $ 0 |
4.3yrs
Average Tenure
57yo
Average Age
Experienced Board: TARA's board of directors are considered experienced (4.3 years average tenure).